http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019103442-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0624908c7150e45bdd907be4f162057e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-907
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-90
filingDate 2018-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab3001409563346f4618467578e4a66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a85dee92f8982c13148fe98d9739c3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8e0fd121d9ca68a8953cac607923f3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2a3d1863ef95fd4bbb034da8f7e23e7
publicationDate 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019103442-A3
titleOfInvention Genome editing composition using crispr/cpf1 system and use thereof
abstract The present invention relates to a genome editing composition using a CRISPR/Cpf1 system and a use thereof and, more particularly, to a genome editing composition comprising: a CRISPR RNA (crRNA) including a guide sequence capable of hybridizing with a target nucleotide sequence, and a uridine repeat sequence connected to the 3'-terminus of the guide sequence, or a DNA coding therefor; and a Cpf1 protein or a DNA coding therefor, a genome editing method using the same, a method for construction of a transgenic entity, and a transgenic entity. Utilizing the CRIPSPR/Cpf1 system, the present invention can increase an indel efficiency and decrease off-target activity in genome editing and thus can easily construct a transformed cell or transgenic animal or plant having a desired gene inserted thereinto (knock-in) or deleted therefrom (knock-out).
priorityDate 2017-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170068400-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170063399-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6029

Total number of triples: 37.